© 2023 Vial. All rights reserved
Vial is speaking at the 2023 BIO CEO & Investor Conference
February 6-9, 2023 | New York, NY
Vial is proud to be a Premier Program Sponsor at this years 2023 BIO CEO & Investor Conference. In addition, Simon Burns, CEO & Co-Founder will be speaking on the educational panel for ‘Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period‘. To request a meeting, please request using the exclusive BIO One-on-One Partnering™ platform or submit using the form below.
Vial will be at SCOPE 14th Annual Summit
February 6-9, 2023 | Orlando, FL
Vial is excited to attend the Summit for Clinical Ops Executives this year in Orlando, FL. The programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations.
Vial will be at the BIO International Convention
June 5-8, 2023 | Boston, MA
Vial is proud to be an exhibitor at the 2023 BIO International Convention, booth #2885. The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.
Vial will be at the 41st Annual J.P. Morgan Healthcare Conference
January 9-12, 2023 | San Francisco, CA
The 41st Annual J.P. Morgan Health Care Conference will take place January 9-12, 2023 in San Francisco, CA. Simon Burns, CEO & Co-Founder will represent Vial at this event alongside several team members. #JPM2023 is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growing companies, innovative technology creators and members of the investment community. Vial is thrilled to be invited to attend.
Vial is presenting at the Biotech Showcase
January 9-11, 2023 | San Francisco, CA
Vial is excited to present at Biotech Showcase for JPM 2023.
Webinar: Reimagining Clinical Trials to Deliver Faster, Higher Quality Trials for Sponsors
On Demand | Online
Join Simon Burns, Vial CEO and Co-Founder, Rich McCormick, VP of Oncology, and Luke Bogus, Product Manager, as they discusses Vial’s tech-enabled clinical trials.